T2 detection of tumor invasion within segmented components of glioblastoma multiforme

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 2, 2009, Pages 251-257

  McMillan, Kathryn M ^a,b   Ehtesham, Moneeb ^a   Stevenson, Charles B ^a   Edgeworth, Michael L ^a   Thompson, Reid C ^a   Price, Ronald R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

CXCR4; Gliomablastoma multiforme; MRI; Tumor invasion

Indexed keywords

CHEMOKINE RECEPTOR CXCR4;

ADULT; AGED; ARTICLE; BASAL GANGLION; CANCER INVASION; CEREBROSPINAL FLUID; CONTROLLED STUDY; GLIOBLASTOMA; GRAY MATTER; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CONTRAST MEDIA; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTORS, CXCR4;

EID: 60549111265     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21659     Document Type: Article

References (57)

1. Nagashima G, Suzuki R, Hokaku H, et al. Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma. Surg Neurol 1999;51:292-299.
2. Burger JA, Kipps TJ. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006;107: 1761-1767.
3. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-56.
4. Zeelenberg IS, Ruuls-Van Stalle L, Roos E. The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. Cancer Res 2003;63:3833-3839.
5. Engl T, Relja B, Marian D, et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006;8:290-301.
6. Saur D, Seidler B, Schneider G, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology 2005;129:1237-1250.
7. Su L, Zhang J, Xu H, et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin Cancer Res 2005;11:8273-8280.
8. Barbero S, Bonavia R, Bajetto A, et al. Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 2003;63:1969-1974.
9. Ehtesham M, Winston JA, Kabos P, Thompson RC. CXCR4 expression mediates glioma cell invasiveness. Oncogene 2006;25:2801-2806.
10. Rubin JB, Kung AL, Klein RS, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 2003;100:13513-13518.
11. Zhou Y, Larsen PH, Hao C, Yong VW. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002;277:49481-49487.
12. Salmaggi A, Gelati M, Pollo B, et al. CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 2004;67:305-317.
13. Ehtesham M, Stevenson C, McMillan K, Price R, Thompson RC. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peri-tumoral T2-weighted signal abnormalities. Neurosurgery 2008;63:560-570.
14. Galanis E, Buckner JC, Maurer MJ, et al. Validation of neuroradiologic response assessment in gliomas: measurement by RE- CIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methods. Neurooncology 2006;8:156-165.
15. Sampson JH, Raghavan R, Provenzale JM, et al. Induction of hy- perintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol 2007;188: 703-709.
16. Shukla D, Huilgol NG, Trivedi N, Mekala C. T2 weighted MRI in assessment of volume changes during radiotherapy of high grade gliomas. J Cancer Res Ther 2005;1:235-238.
17. Tsuyumu M, Isotani E, Nariai T, Suzuki R, Matsushima Y, Hirakawa K. [Perifocal abnormal signal intensity area in MRI in meningiomas.] No Shinkei Geka 1989;17:319-325.
18. Bydder GM, Steiner RE. NMR imaging of the brain. Neuroradiology 1982;23:231-240.
19. Chatel M, Darcel F, de Certaines JD, Benoist L, Bernard AM. T2 proton nuclear magnetic resonance relaxation times in vitro and human intracranial tumours. J Neurooncol 1986;1986:315-321.
20. Holland BA, Brant-Zawadzki M, Norman D, Newton TH. Magnetic resonance imaging of primary intracranial tumors: a review. Int J Radiat Oncol Biol Phys 1985;11:315-321.
21. Jezernick M, Sentjurc M, Schara M. Proton magnetic resonance characterization of brain tumors. Acta Neurol 1983;67:1-9.
22. Just M, Thelen M. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. Radiology 1988;169:779-785.
23. Ngo FQ, Bay JW, Kurland RJ, et al. Magnetic resonance of brain tumors: considerations of imaging contrast on the basis of relaxation measurements. Magn Reson Imaging 1985;3:145-155.
24. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation- maximization algorithm. IEEE Trans Med Imaging 2001;20:45-57.
25. Pham D, Xu C, Prince J. A survey of current methods in medical image segmentation. Annu Rev Biomed Eng 1998;s:1-27.
26. van Buchem MA, McGowan JC, Kolson DL, Polansky M, Grossman RI. Quantitative volumetric magnetization transfer analysis in multiple sclerosis: estimation of macroscopic and microscopic disease burden. Magn Reson Med 1996;36:632-636.
27. Bozzali M, Franceschi M, Falini A, et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 2001;57:1135-1137.
28. Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000;54:186-193.
29. Yamamoto A, Miki Y, Adachi S, et al. Whole brain magnetization transfer histogram analysis of pediatric acute lymphoblastic leukemia patients receiving intrathecal methotrexate therapy. Eur J Radiol 2006;57:423-427.
30. Benedict RH, Bruce J, Dwyer MG, et al. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis. Mult Scler 2007;13:722-730.
31. Tavazzi E, Dwyer MG, Weinstock-Guttman B, et al. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage 2007;36:746-754.
32. Tortorella P, Rocca MA, Mezzapesa DM, et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol 2006;253:903-907.
33. Yu CS, Li KC, Lin FC, Jiang TZ, Sun H, Chen B. [Diffusion tensor imaging of the normal-appearing brain tissue in relapsing-remit- ting multiple sclerosis.] Zhonghua Yi Xue Za Zhi 2006;86:1260-1264.
34. Oliveira de Andrade DC, Borba EF, Bonfá E, et al. Quantifying subclinical central nervous lesions in primary antiphospholipid syndrome: The role of magnetization transfer imaging. J Magn Reson Imaging 2008;27:483-488.
35. Mork S, Laerum OD, deRitter L. Invasiveness of tumours of the central nervous system. In: Tumor invasion. Oxford: Oxford University Press; 1984. p 79-125.
36. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005;23:2411-2422.
37. Herlidou-Mlme S, Constans JM, Carsin B, et al. MRI texture analysis on texture test objects, normal brain and intracranial tumors. Magn Reson Imaging 2003;21:989-993.
38. Lau PY, Ozawa S, Voon FC. Using block-based multiparameter representation to detect tumor features on T2-weighted brain MRI images. Methods Inf Med 2007;46:236-241.
39. Soltanian-Zadeh H, Peck DJ. Feature space analysis: effects of MRI protocols. Med Phys 2001;28:2344-2351.
40. Soltanian-Zadeh H, Windham JP, Peck DJ, Mikkelsen T. Feature space analysis of MRI. Magn Reson Med 1998;40:443-453.
41. Vaidyanathan M, Clarke LP, Hall LO, et al. Monitoring brain tumor response to therapy using MRI segmentation. Magn Reson Imaging 1997;15:323-334.
42. Vinitski S, Gonzalez CF, Knobler R, Andrews D, Iwanaga T, Curtis M. Fast tissue segmentation based on a 4D feature map in characterization of intracranial lesions. J Magn Reson Imaging 1999;9:768-776.
43. Yee Lau P, Voon FCT, Ozawa S. The detection and visualization of brain tumors on T2-weighted MRI images using multiparameter feature blocks. IEEE Eng Med Biol Soc Conf 2005;5:5104-5107.
44. Kelly P, Daumas-Duport C, Kispert D, Kall B, Scheithauer B, Illig J. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-874.
45. Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE. Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol 1996;27:65-73.
46. Pope WB, Sayre J, Perlina A, Villablanca JP, Mischel PS, Cloughesy TF. MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 2005;26:2466-2474.
47. Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG 2nd. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma. Clin Cancer Res 2005;11(24 Pt 1):8600-8605.
48. Carlson MR, Pope WB, Horvath S, et al. Relationship between survival and edema in malignant gliomas: role of vascular endo- thelial growth factor and neuronal pentraxin 2. Clin Cancer Res 2007;13:2592-2598.
49. Yang YS, Guccione S, Bednarski MD. Comparing genomic and histologic correlations to radiographic changes in tumors: a murine SCC VII model study. Acad Radiol 2003;10:1165-1175.
50. Diehn M, Nardini C, Wang DS, et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proc Natl Acad SciUSA2008;105:5213-5218.
51. Hobbs SK, Shi G, Homer R, Harsh G, Atlas SW, Bednarski MD. Magnetic resonance image-guided proteomics of human glioblastoma multiforme. J Magn Resonance Imaging 2003;18:530-536.
52. Van Meter T, Dumur C, Hafez N, Garrett C, Fillmore H, Broaddus WC. Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets. Diagn Mol Pathol B 2006;15:195-205.
53. Mineura K, Sasajima T, Kowada M, Uesaka Y, Shishido F. Innovative approach in the diagnosis of gliomatosis cerebri using carbon 11-L-methionine positron emission tomography. J Nucl Med 1991;32:726-728.
54. Gilad AA, Winnard PT Jr, van Zijl PC, Bulte JW. Developing MR reporter genes: promises and pitfalls. NMR Biomed 2007;20:275-290.
55. Schaller BJ, Modo M, Buchfelder M. Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol 2007;9:60-71.
56. Torigian DA, Huang SS, Houseni M, Alavi A. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin 2007;57:206-224.
57. Shaughnessy JD Jr, Haessler J, van Rhee F, et al. Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics. Br J Haematol 2007;137:530-536.